Masaya Sato

23PUBLICATIONS
21CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPredictive and prognostic markersMetabolic medicineBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 08, 2026
Rapid Intrasegmental Progression After Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma: Incidence, Imaging Features, and Clinical Outcomes.

|Jun 03, 2026
Toward a Synthetic Data Revolution: Diffusion Model-Enhanced Hepatocellular Carcinoma Prediction in Steatotic Liver Disease.

|Apr 21, 2026
Management and Prognosis of HCC Patients With Elevated Tumor Markers but no Imaging Recurrence After Radiofrequency Ablation.

|Jan 23, 2026
Machine Learning Approach Enables Highly Accurate Identification of At-Risk Metabolic Dysfunction-Associated Steatohepatitis.

Masaya Sato, Takuma Nakatsuka, Tatsuya Minami

|Oct 01, 2025
Pre-Treatment Liver Stiffness Is a Stronger Predictor of Hepatocellular Carcinoma Development Than Post-Treatment Liver Stiffness After Hepatitis C Virus Eradication.

Takuma Nakatsuka, Ryo Nakagomi, Keisuke Mabuchi

|May 30, 2025
Predicting the risk of developing diabetes in steatotic liver disease using controlled attenuation parameter in a health checkup population.

Takuma Nakatsuka, Yutaka Yamaji, Ryosuke Tateishi

Pageof 4

Frequent Collaborators

14 joint publications

Ryosuke Tateishi

7 joint publications

Takuma Nakatsuka

6 joint publications

Mitsuhiro Fujishiro

4 joint publications

Tomoharu Yamada